Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Bevacizumab in Metastatic Melanoma
NCT00568048Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in melanoma, sponsored by Swiss Group for Clinical Cancer Research. Started Dec 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00568048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568048.